JP Patent
JP4949582B2 — 新規アミノチアゾール誘導体、それらの製造およびそれらを含有する医薬組成物
Assigned to Sanofi SA · Expires 2012-06-13 · 14y expired
What this patent protects
Patent listed against Crenessity.
Drugs covered by this patent
- Crenessity (CRINECERFONT) · Neurocrine
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.